Search Results - "Ramm, Carole"

Lack of Complete Pretreatment Staging Is Associated With Omission of Neoadjuvant Therapy for Rectal Cancer: A Statewide Study by Tang, Dalun, Rivard, Samantha J., Weng, Wenjing, Ramm, Carole A., Cleary, Robert K., Hendren, Samantha

“…Standardized local staging and neoadjuvant therapy are rectal cancer management quality measures supported by the Commission on Cancer and National…”
Get full text

Postoperative Oral Rehydration and Regimented Follow-up Decrease Readmissions After Colorectal Surgery That Includes Ileostomies by Westfall, Kristen M, Rivard, Samantha J, Suwanabol, Pasithorn A, Albright, Jeremy J, Ramm, Carole A, Cleary, Robert K

“…Ileostomies constitute 15% to 43% of readmissions after colorectal surgery, often due to dehydration and acute kidney injury. Prior institutional interventions…”
Get full text

Single-Dose Study of a Corticotropin-Releasing Factor Receptor-1 Antagonist in Women With 21-Hydroxylase Deficiency by Turcu, Adina F, Spencer-Segal, Joanna L, Farber, Robert H, Luo, Rosa, Grigoriadis, Dimitri E, Ramm, Carole A, Madrigal, David, Muth, Tim, O'Brien, Christopher F, Auchus, Richard J

“…Context: Treatment of 21-hydroxylase deficiency (21OHD) is difficult to optimize. Normalization of excessive ACTH and adrenal steroid production commonly…”
Get full text

The Combination of Insulin-Like Growth Factor Receptor 1 (IGF1R) Antibody Cixutumumab and Mitotane as a First-Line Therapy for Patients with Recurrent/Metastatic Adrenocortical Carcinoma: a Multi-institutional NCI-Sponsored Trial by Lerario, Antonio M., Worden, Francis P., Ramm, Carole A., Hasseltine, Elizabeth A., Stadler, Walter M., Else, Tobias, Shah, Manisha H., Agamah, Edem, Rao, Krishna, Hammer, Gary D.

“…Adrenocortical carcinoma (ACC) is an aggressive malignancy, which lacks an effective systemic treatment. Abnormal activation of insulin-like growth factor…”
Get full text

Early discharge after enhanced recovery rectal resection does not increase emergency department visits and readmissions: a single institution analysis by Kamara, Maseray, Baur, Katherine, Langmeyer, Jessie, Huebner, Marianne, Ramm, Carole, Cleary, Robert K.

“…Background Same-day discharge after colectomy in enhanced recovery pathways has been shown to be feasible. It is not clear how early patients with rectal…”
Get full text

Postoperative Oral Rehydration and Regimented Follow-up Decrease Readmissions for Colorectal Surgery Patients with Ileostomies by Westfall, Kristen M., Rivard, Samantha J., Suwanabol, Pasithorn A., Albright, Jeremy, Ramm, Carole, Cleary, Robert K.

“…BACKGROUND: Ileostomies constitute 15-43% of readmissions after colorectal surgery, often due to dehydration and acute kidney injury. Prior institutional…”
Get full text

Lack of Complete Pretreatment Staging Is Associated With Omission of Neoadjuvant Therapy for Rectal Cancer: A Statewide Study by Tang, Dalun, Rivard, Samantha, Weng, Wenjing, Ramm, Carole A, Cleary, Robert K., Hendren, Samantha

Get full text

Operative trends following the adoption of nonoperative management of rectal cancer by Brewer, Justin, Kamara, Maseray, Huebner, Marianne, Taxakis, Elias, Grajewski, Karen, Ramm, Carole, Cleary, Robert K.

“…Background Differentiating clinical near‐complete and complete responses (cCR) after neoadjuvant therapy (NT) is challenging in rectal cancer patients. We…”
Get full text

Early Discharge after Enhanced Recovery Colectomy Does Not Increase Emergency Department Visits and Readmissions: A Single Institution Analysis by Baur, Katherine, Sood, Evan M, Huebner, Marianne, Ramm, Carole, Kolli, Nivya, Cleary, Robert K

“…Same-day discharge after colorectal surgery in enhanced recovery pathways is increasing. This study aimed to determine if discharge on postoperative days (POD)…”
Get more information

Pain and opioid use after colorectal resection for benign versus malignant disease: A single institution analysis by Diaz, Sarah, Brockhaus, Kara K., Bobel, Matthew C., Colom, Sara M., Ramm, Carole, Cleary, Robert K.

“…Studies comparing opioid needs between benign and malignant colorectal diseases are inconclusive. Single institution analysis of prospectively maintained…”
Get full text

Alvimopan is associated with favorable outcomes in open and minimally invasive colorectal surgery: a regional database analysis by Kaarto, Patricia, Westfall, Kristen M., Brockhaus, Kara, Paulus, Amanda L., Albright, Jeremy, Ramm, Carole, Cleary, Robert K.

“…Background Alvimopan is a µ-opioid receptor antagonist associated with shorter time to gastrointestinal recovery in patients having open colorectal surgery…”
Get full text

Comparison of surgeon and pathologist total mesorectal excision grade after rectal cancer resection: A single institution analysis by Kato, Patrick J., Kanters, Arielle E., Rivard, Samantha J., Hendren, Samantha, Ramm, Carole, Albright, Jeremy, Schumaker, Kate E., Cleary, Robert K.

“…Background A Michigan Surgical Quality Collaborative Colorectal Cancer Project initiative sought to increase adoption of surgeon total mesorectal excision…”
Get full text

Abiraterone Acetate to Lower Androgens in Women With Classic 21-Hydroxylase Deficiency by Auchus, Richard J, Buschur, Elizabeth O, Chang, Alice Y, Hammer, Gary D, Ramm, Carole, Madrigal, David, Wang, George, Gonzalez, Martha, Xu, Xu Steven, Smit, Johan W, Jiao, James, Yu, Margaret K

“…Context: Chronic supraphysiological glucocorticoid therapy controls the androgen excess of 21-hydroxylase deficiency (21OHD) but contributes to the high…”
Get full text

Erratum to: The Combination of Insulin-Like Growth Factor Receptor 1 (IGF1R) Antibody Cixutumumab and Mitotane as a First-Line Therapy for Patients with Recurrent/Metastatic Adrenocortical Carcinoma: a Multi-institutional NCI-Sponsored Trial by Lerario, Antonio M., Worden, Francis P., Ramm, Carole A., Hesseltine, Elizabeth A., Stadler, Walter M., Else, Tobias, Shah, Manisha H., Agamah, Edem, Rao, Krishna, Hammer, Gary D.

Get full text